Literature DB >> 32434942

Therapeutic CMP-Nonulosonates against Multidrug-Resistant Neisseria gonorrhoeae.

Sunita Gulati1, Ian C Schoenhofen2, Theresa Lindhout-Djukic3, Melissa J Schur3, Corinna S Landig4,5, Sudeshna Saha4,5, Lingquan Deng4,5, Lisa A Lewis1, Bo Zheng1, Ajit Varki4,5, Sanjay Ram6.   

Abstract

Neisseria gonorrhoeae deploys a unique immune evasion strategy wherein the lacto-N-neotetraose termini of lipooligosaccharide (LOS) are "capped" by a surface LOS sialyltransferase (Lst), using extracellular host-derived CMP-sialic acid (CMP-Neu5Ac in humans). LOS sialylation enhances complement resistance by recruiting factor H (FH; alternative complement pathway inhibitor) and also by limiting classical pathway activation. Sialylated LOS also engages inhibitory Siglecs on host leukocytes, dampening innate immunity. Previously, we showed that analogues of CMP-sialic acids (CMP-nonulosonates [CMP-NulOs]), such as CMP-Leg5,7Ac2 and CMP-Neu5Ac9N3, are also substrates for Lst. Incorporation of Leg5,7Ac2 and Neu5Ac9N3 into LOS results in N. gonorrhoeae being fully serum sensitive. Importantly, intravaginal administration of CMP-Leg5,7Ac2 attenuated N. gonorrhoeae colonization of mouse vaginas. In this study, we characterize and develop additional candidate therapeutic CMP-NulOs. CMP-ketodeoxynonulosonate (CMP-Kdn) and CMP-Kdn7N3, but not CMP-Neu4,5Ac2, were substrates for Lst, further elucidating gonococcal Lst specificity. Lacto-N-neotetraose LOS capped with Kdn and Kdn7N3 bound FH to levels ∼60% of that seen with Neu5Ac and enabled gonococci to resist low (3.3%) but not higher (10%) concentrations of human complement. CMP-Kdn, CMP-Neu5Ac9N3, and CMP-Leg5,7Ac2 administered intravaginally (10 μg/d) to N. gonorrhoeae-colonized mice were equally efficacious. Of the three CMP-NulOs above, CMP-Leg5,7Ac2 was the most pH and temperature stable. In addition, Leg5,7Ac2-fed human cells did not display this NulO on their surface. Moreover, CMP-Leg5,7Ac2 was efficacious against several multidrug-resistant gonococci in mice with a humanized sialome (Cmah-/- mice) or humanized complement system (FH/C4b-binding protein transgenic mice). CMP-Leg5,7Ac2 and CMP-Kdn remain viable leads as topical preventive/therapeutic agents against the global threat of multidrug-resistant N. gonorrhoeae.
Copyright © 2020 National Research Council of Canada. This article is distributed under the terms of the CC BY 4.0 Unported license.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32434942      PMCID: PMC7321800          DOI: 10.4049/jimmunol.1901398

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

1.  Total synthesis of legionaminic acid as basis for serological studies.

Authors:  Stefan Matthies; Pierre Stallforth; Peter H Seeberger
Journal:  J Am Chem Soc       Date:  2015-02-19       Impact factor: 15.419

2.  Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection.

Authors:  Hong Wu; Ann E Jerse
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.

Authors:  Sunita Gulati; Sarika Agarwal; Shreekant Vasudhev; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

4.  New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance.

Authors:  David A Lewis
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706

5.  Influence of pH on vaginal discharges.

Authors:  L Cohen
Journal:  Br J Vener Dis       Date:  1969-09

6.  Biofilm Formation by Neisseria gonorrhoeae.

Authors:  L L Greiner; J L Edwards; J Shao; C Rabinak; D Entz; M A Apicella
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid.

Authors:  Kalyan Banda; Christopher J Gregg; Renee Chow; Nissi M Varki; Ajit Varki
Journal:  J Biol Chem       Date:  2012-06-12       Impact factor: 5.157

8.  N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution.

Authors:  Maria Hedlund; Pam Tangvoranuntakul; Hiromu Takematsu; Jeffrey M Long; Gary D Housley; Yasunori Kozutsumi; Akemi Suzuki; Anthony Wynshaw-Boris; Allen F Ryan; Richard L Gallo; Nissi Varki; Ajit Varki
Journal:  Mol Cell Biol       Date:  2007-04-09       Impact factor: 4.272

9.  Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections.

Authors:  Ann E Jerse; Hong Wu; Mathanraj Packiam; Rachel A Vonck; Afrin A Begum; Lotisha E Garvin
Journal:  Front Microbiol       Date:  2011-07-01       Impact factor: 5.640

10.  Variation of gonococcal lipooligosaccharide structure is due to alterations in poly-G tracts in lgt genes encoding glycosyl transferases.

Authors:  Q L Yang; E C Gotschlich
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  3 in total

1.  Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins.

Authors:  Sunita Gulati; Ian C Schoenhofen; Theresa Lindhout-Djukic; Lisa A Lewis; Iesha Y Moustafa; Sudeshna Saha; Bo Zheng; Nancy Nowak; Peter A Rice; Ajit Varki; Sanjay Ram
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

Review 2.  Hijacking Factor H for Complement Immune Evasion.

Authors:  Sara R Moore; Smrithi S Menon; Claudio Cortes; Viviana P Ferreira
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

3.  Identification of distinct capsule types associated with Serratia marcescens infection isolates.

Authors:  Mark T Anderson; Stephanie D Himpsl; Lindsay A Mitchell; Leandra G Kingsley; Elizabeth P Snider; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2022-03-30       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.